Mar 17 2018
Modified Nijmegen Bethesda Assay
On March 13, 2018. Precision BioLogic Inc., Dartmouth, NS, announced their development of a new approach to standardize and improve factor VIII inhibitor testing. Their press release (tap or click) referenced new data presented in a poster at the Thrombosis and Hemostasis Societies of North America, March 8–10, 2018 meeting, in San Diego, CA, USA. […]
read more